Crystal structure of human MMP9 in complex with a reverse hydroxamate inhibitor

Journal of Molecular Biology

Volumn 319, Issue 1, 2002, Pages 173-181

  Rowsell, Siân ^a   Hawtin, Paul ^a   Minshull, Claire A ^a   Jepson, Holly ^a   Brockbank, Sarah M V ^a   Barratt, Derek G ^a   Slater, Anthony M ^a   McPheat, William L ^a   Waterson, David ^a   Henney, Adriano M ^a   Pauptit, Richard A ^a  

^a ASTRAZENECA   (United Kingdom)

Author keywords

Cardiovascular disease; Crystal structure; Gelatinase; Matrix metalloproteinase; MMP9

Indexed keywords

COLLAGENASE; GLUTAMIC ACID; HISTIDINE; HYDROXAMIC ACID; MATRILYSIN; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR; ZINC ION;

ACUTE HEART INFARCTION; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR SYSTEM; CONNECTIVE TISSUE; CRYSTAL STRUCTURE; ENZYME ACTIVE SITE; ENZYME ACTIVITY; GENETIC MANIPULATION; HEART FAILURE; HEART VENTRICLE REMODELING; PATHOGENESIS; PRIORITY JOURNAL; TISSUE REGENERATION;

EID: 18444397733     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2836(02)00262-0     Document Type: Article

References (34)

1. Extracellular matrix degradation
2. Extracellular matrix degradation
3. Proteolytic remodeling of extracellular matrix
4. Design and therapeutic application of matrix metalloproteinase inhibitors
5. Partial purification and characterization of a neutral protease which cleaves type IV collagen
6. H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen
7. SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages
8. Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridisation
9. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques
10. Matrix metalloproteinases and cardiovascular disease
11. Identification of 92 kD gelatinase in human coronary atherosclerotic lesions. Association of active enzyme synthesis with unstable angina
12. Matrix metalloproteinase inhibition attenuates early left ventricular enlargement after experimental myocardial infarction in mice
13. The role of the C-terminal domain of human collagenase-3 (MMP-13) in the activation of procollagenase-3, substrate specificity, and tissue inhibitor of metallo-proteinase interaction
14. The helping hand of collagenase-3 (MMP-13): 2.7 Å crystal structure of its C-terminal haemopexin-like domain
15. Structure of human pro-matrix metallo-proteinase-2: Activation mechanism revealed
16. The structural basis for the elastolytic activity of the 92-kDa and 72-kDa gelatinases. Role of the fibronectin type II-like repeats
17. X-ray structure of gelatinase A catalytic domain complexed with a hydroxamate inhibitor
18. Structural properties of matrix metalloproteinases
19. Crystal structures of MMP-1 and -13 reveal the structural basis for selectivity of collagenase inhibitors
20. Matrilysin-inhibitor complexes: Common themes among metalloproteases
21. X-ray structure of a hydroxamate inhibitor complex of stromelysin catalytic domain and its comparison with members of the zinc metalloproteinase superfamily
22. Structure determination and analysis of human neutrophil collagenase complexed with a hydroxamate inhibitor
23. X-ray structures of human neutrophil collagenase complexed with peptide hydroxamate and peptide thiol inhibitors. Implications for substrate binding and rational drug design
24. Substrate specificity determinants of human macrophage elastase (MMP-12) based on the 1.1 Å crystal structure
25. Crystal structure of human macrophage elastase (MMP-12) in complex with a hydroxamic acid inhibitor
26. Expression, characterization and structure determination of an active site mutant (Glu202-Gln) of ministromelysin-1
27. The CCP4 suite: Programs for protein crystallography
28. Inhibition of stromelysin-1 (MMP-3) by P1′-biphenylylethyl carboxyalkyl dipeptides
29. Crystallographic R factor refinement by molecular dynamics
30. Protein hydration observed by X-ray diffraction. Solvation properties of penicillopepsin and neuraminidase crystal structures
31. An extensively modified version of MolScript that includes greatly enhanced coloring capabilities
32. A fast algorithm for rendering space-filling molecule pictures
33. Raster3D version 2.0: A program for photorealistic molecular graphics
34. Protein folding and association: Insights from the interfacial and thermodynamic properties of hydrocarbons